openPR Logo
Press release

Acute Pancreatitis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | CalciMedica, Inc, Regeneron Pharmaceuticals, SCM Lifescience Co., LTD., Pfizer, Repligen Corporation

10-18-2023 06:03 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Acute Pancreatitis Market is Predicted to Exhibit Remarkable

DelveInsight's "Acute Pancreatitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Acute Pancreatitis, historical and forecasted epidemiology as well as the Acute Pancreatitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Acute Pancreatitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acute Pancreatitis Market Forecast
https://www.delveinsight.com/sample-request/acute-pancreatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Acute Pancreatitis Market Report:
• The Acute Pancreatitis market size was valued approximately USD 714 million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In 2021, there were roughly 504,720 incident instances of acute pancreatitis (AP) worldwide, with the United States having the highest number of these cases. About 159,343 cases were reported in the EU-5 in 2021
• According to projections from DelveInsight, there were roughly 283,657 incident instances of Acute Pancreatitis in the United States in 2021, and this number is anticipated to rise during the study period (2019-2032)
• The incidence population of Acute Pancreatitis in Japan was discovered to be around 61,721 cases in 2021; this number is expected to change by 2032
• There were 42,549 severe cases of Acute Pancreatitis in the United States in 2021, followed by 226.925 mild cases. Throughout the study period (2019-2032), a rise in cases with a particular severity is anticipated
• Key Acute Pancreatitis Companies: CalciMedica, Inc, Regeneron Pharmaceuticals, SCM Lifescience Co., LTD., Pfizer, Repligen Corporation, and others
• Key Acute Pancreatitis Therapies: Auxora, REGN1500, SCM-AGH, CM4620, meropenem, RG1068, evinacumab, and others
• The Acute Pancreatitis epidemiology based on gender analyzed that Acute Pancreatitis affected males more than females
• The Acute Pancreatitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acute Pancreatitis pipeline products will significantly revolutionize the Acute Pancreatitis market dynamics.

Acute Pancreatitis Overview
The exocrine pancreas is characterized by inflammation in acute pancreatitis (AP), which develops as a result of the pancreas' own auto-digestion by pancreatic enzymes. Acinar cell damage and both a local and systemic inflammatory response are linked to AP.
Get a Free sample for the Acute Pancreatitis Market Report
https://www.delveinsight.com/report-store/acute-pancreatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Acute Pancreatitis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Acute Pancreatitis Epidemiology Segmentation:
The Acute Pancreatitis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Acute Pancreatitis
• Prevalent Cases of Acute Pancreatitis by severity
• Gender-specific Prevalence of Acute Pancreatitis
• Diagnosed Cases of Episodic and Chronic Acute Pancreatitis

Download the report to understand which factors are driving Acute Pancreatitis epidemiology trends @ Acute Pancreatitis Epidemiology Forecast
https://www.delveinsight.com/sample-request/acute-pancreatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Acute Pancreatitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acute Pancreatitis market or expected to get launched during the study period. The analysis covers Acute Pancreatitis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Acute Pancreatitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Acute Pancreatitis Therapies and Key Companies
• Auxora: CalciMedica, Inc
• REGN1500: Regeneron Pharmaceuticals
• SCM-AGH: SCM Lifescience Co., LTD.
• CM4620: CalciMedica, Inc
• meropenem: Pfizer
• RG1068: Repligen Corporation
• evinacumab: Regeneron Pharma

Discover more about therapies set to grab major Acute Pancreatitis market share @ Acute Pancreatitis Treatment Market
https://www.delveinsight.com/sample-request/acute-pancreatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Acute Pancreatitis Market Drivers
• Increasing Incidence and Severity
• Increasing Collaborations
• Lack of approved pharmacologic therapies

Acute Pancreatitis Market Barriers
• Lack of awareness
• Higher R&D Investment
• Lack of Standardized Diagnostics and Treatment

Scope of the Acute Pancreatitis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Acute Pancreatitis Companies: CalciMedica, Inc, Regeneron Pharmaceuticals, SCM Lifescience Co., LTD., Pfizer, Repligen Corporation, and others
• Key Acute Pancreatitis Therapies: Auxora, REGN1500, SCM-AGH, CM4620, meropenem, RG1068, evinacumab, and others
• Acute Pancreatitis Therapeutic Assessment: Acute Pancreatitis current marketed and Acute Pancreatitis emerging therapies
• Acute Pancreatitis Market Dynamics: Acute Pancreatitis market drivers and Acute Pancreatitis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Acute Pancreatitis Unmet Needs, KOL's views, Analyst's views, Acute Pancreatitis Market Access and Reimbursement

To know more about Acute Pancreatitis companies working in the treatment market, visit @ Acute Pancreatitis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/acute-pancreatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Acute Pancreatitis Market Report Introduction
2. Executive Summary for Acute Pancreatitis
3. SWOT analysis of Acute Pancreatitis
4. Acute Pancreatitis Patient Share (%) Overview at a Glance
5. Acute Pancreatitis Market Overview at a Glance
6. Acute Pancreatitis Disease Background and Overview
7. Acute Pancreatitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Acute Pancreatitis
9. Acute Pancreatitis Current Treatment and Medical Practices
10. Acute Pancreatitis Unmet Needs
11. Acute Pancreatitis Emerging Therapies
12. Acute Pancreatitis Market Outlook
13. Country-Wise Acute Pancreatitis Market Analysis (2019-2032)
14. Acute Pancreatitis Market Access and Reimbursement of Therapies
15. Acute Pancreatitis Market Drivers
16. Acute Pancreatitis Market Barriers
17. Acute Pancreatitis Appendix
18. Acute Pancreatitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Acute Pancreatitis Pipeline
https://www.delveinsight.com/report-store/acute-pancreatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Acute Pancreatitis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Acute Pancreatitis market. A detailed picture of the Acute Pancreatitis pipeline landscape is provided, which includes the disease overview and Acute Pancreatitis treatment guidelines.
Acute Pancreatitis Epidemiology
https://www.delveinsight.com/report-store/acute-pancreatitis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Acute Pancreatitis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Acute Pancreatitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Protein Supplements Market
https://www.delveinsight.com/report-store/protein-supplements-market
Protein Supplements Market By Source (Animal-Based [Whey, Casein, Fish, Eggs, Others], Plant-Based [Soy, Rice, Pea, Spirulina, Others]), By Product Type (Protein Powders, Protein Bars, Ready-To-Drink, And Others), By Application (Sports Nutrition And Functional Foods), By Distribution Channel (Supermarkets And Hypermarkets, E-Commerce, Direct-To-Consumer, Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to the growing consumer awareness of having a protein rich diet,

Proteomics Market
https://www.delveinsight.com/report-store/prostate-cancer-market-insight
Proteomics Market By Product & Services (Instrumentation Technology [Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, And Other], Reagents & Consumables, And Software & Services), By Application (Clinical Diagnostics, Drug Discovery, And Others), By End-User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028.

Infrared Thermometer Market
https://www.delveinsight.com/report-store/infrared-thermometer-market
Infrared Thermometer Market By Product Type (Contact Thermometers And Non-Contact Thermometers), By End-User (Food And Beverage Industry, Electronic Industry, Healthcare Industry, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the growing need for robust temperature measuring devices in critical industries and rise in the number of infectious diseases across the globe.

Hemoglobinopathies Market
https://www.delveinsight.com/report-store/sport-nutrition-market
Hemoglobinopathies Market By Indication (Thalassemia, Sickle Cell Anaemia, And Others), By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2027 owing to the increasing prevalence of various hemoglobin disorders and the increasing research & developmental activities concerning to the hemoglobinopathies across the globe

Sport Nutrition Market
https://www.delveinsight.com/report-store/sport-nutrition-market
The Sports Nutrition Market By Product Type (Sports Drinks And Sports Supplements), By Distribution Channels (Hypermarkets & Supermarkets, E-Commerce, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing inclination toward following healthy and active lifestyle and growing importance of sports nutrition among athletes and sportspersons.

Endodontic Devices Market
https://www.delveinsight.com/report-store/endodontic-devices-market
Endodontic Devices Market By Product Type (Instruments [Apex Locators, Endodontic Motors, Endodontic Scalers, Endodontic Lasers, Handpieces, Machine-Assisted Obturation Systems, And Others], Consumables [Obturation, Access Cavity Preparation, Shaping And Cleaning]), By End-User (Dental Hospitals, Dental Clinics, And Others), and by geography is estimated to register growth at a remarkable CAGR during the forecast period from 2023-2028 owing to the rising patient pool associated with dental disorders, poor oral health, leading to increased number of root canal treatments, the increasing population opting for dental aesthetics, among others across the globe.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Pancreatitis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | CalciMedica, Inc, Regeneron Pharmaceuticals, SCM Lifescience Co., LTD., Pfizer, Repligen Corporation here

News-ID: 3255526 • Views:

More Releases from DelveInsight Business Research

Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Companies
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, DelveInsight Finds
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics. DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,

All 5 Releases


More Releases for Acute

Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth